Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 31.30
0.00 (0.00%)
Oct 8, 2026, 12:50 PM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 1.02 billion as of October 9, 2026. It is the 33,794th most valuable company in the world and the 2,045th biggest in Taiwan. Its market cap has decreased by 6.98% in one year.
Market Cap
1.02B
Enterprise Value
827.78M
Revenue
709.37M
Global Rank
Country Rank
#2,045 Taiwan
PE Ratio
13.43
ChartMarket Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 1.02B, an increase of 306.83%. That is a compound annual growth rate of 6.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.02B | -5.15% |
| Dec 31, 2025 | 1.07B | 3.13% |
| Dec 31, 2024 | 1.04B | 5.09% |
| Dec 29, 2023 | 988.19M | 10.13% |
| Dec 30, 2022 | 897.32M | -7.68% |
| Dec 30, 2021 | 971.96M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.31B |
| Holy Stone Healthcare | 1.24B |
| NeoCore Technology | 1.20B |
| Bio Preventive Medicine | 1.16B |
| Enimmune | 1.16B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |
| GeneReach Biotechnology | 1.01B |